Study on sustainability reports of healthcare sector in India: Evidence from five leading Indian pharmaceutical companies

As a result of its innovations, the pharmaceutical industry is well-positioned to help humanity, achieve wealth and universal health. The COVID-19 emphasizes the significance of these industries to both society and the economy. Nevertheless, the issue of pharmaceutical industry sustainability is gaining greater attention and expectations are rising. The study compares the social, environmental, and economic performance of five pharmaceutical companies. It also looks into the comprehensiveness of sustainability reports published by five top Indian pharmaceutical companies. In this study, the sustainability reports of five pharmaceutical firms were compared and evaluated following GRI 2011 standards. Based on the inclusion of sustainability reports, a numerical score ranging from zero (0) to three (3) has been assigned to each of the 84 performance indicators of the GRI 2011 criteria (9-economic dimension, 30- environmental dimension, 45-social dimension). Analysis has pointed out that economic reporting is much more precise than social and environmental reporting.